Interactions With Healthcare Providers

Amgen requires that all interactions with healthcare providers and other customers comply with all applicable laws and adhere to the highest standards of professional ethics and responsibility.

As a science-driven and values-based company, Amgen is committed to exchanging information with healthcare providers in an ethical and responsible way, with the best interests of patients always in mind. The company has established mandatory standards that all Amgen staff members, consultants, contract workers, and temporary staff must follow when interacting with healthcare professionals and other customers.

Amgen maintains collaborative relationships with healthcare professionals where appropriate to develop new products; determine appropriate and beneficial uses for products; support medical research and other educational, scientific and charitable activities; provide healthcare professionals and the public with information regarding the benefits and risks of Amgen's products; and obtain feedback and advice about Amgen products from medical experts. Amgen requires that all interactions with healthcare professionals and other customers comply with applicable laws. Moreover, we seek to ensure that our interactions with healthcare professionals consistently meet or exceed industry guidelines.

The following are some examples of PhRMA Code provisions, which is available in its entirety at www.phrma.org:

  • Never providing non-educational "reminder" items (such as pens, mugs, or other items branded with a product or company logo). Only distribute to healthcare professionals educational items that advance disease or treatment education and that are not of substantial value ($100 or less);
  • Not offering meals to healthcare professionals, with the exception of occasional, modest meals offered as a business courtesy in conjunction with a presentation that provides scientific or educational information;
  • Never offering or providing any entertainment or recreational items to any healthcare professional who is not a salaried employee of the company; and
  • Keep Independent Medical Education (IME) grant-making functions separate from sales and marketing functions, including by prohibiting the provision of IME funds to influence, advise or provide guidance on products and by not offering compensation to any healthcare professional for expenses or time spent in IME participation.

The U.S. Sunshine Act, also known as the Open Payments—Physician Payments Sunshine Act, was enacted as federal law in 2010 as a provision of the Affordable Care Act. The Sunshine Act requires that health care manufacturers, including Amgen, track financial transactions with certain health care providers (HCPs) and health care organizations (HCOs) and disclose those transactions on an annual basis. We support the Sunshine Act and its goal of providing the public greater visibility into interactions between the health care industry and HCPs to ensure public trust and confidence.

As of November 2024